Advertisement
Screener

NewcelX Ltd. (NCEL) Form 6-K: Report of foreign private issuer, 2024

1.9 / 5 stars · 8/21 Roast Me

Add as a preferred source on Google

NewcelX Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-12-30: Form 6-K; Period of report 2024-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0226253-6k_nlspharma.htm.
  • 2024-12-23: Form 6-K; Period of report 2024-12-23; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0225558-6k_nlspharma.htm.
  • 2024-12-19: Form 6-K/A; Period of report 2024-12-19; Description AMENDMENT NO. 1 TO FORM 6-K; Document ea0225358-6ka1_nlspharma.htm.
  • 2024-12-19: Form 6-K; Period of report 2024-12-19; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0225128-6k_nlspharma.htm.
FiledFormPeriod of reportDescriptionDocument
2024-12-306-K2024-12-30REPORT OF FOREIGN PRIVATE ISSUERea0226253-6k_nlspharma.htm
2024-12-236-K2024-12-23REPORT OF FOREIGN PRIVATE ISSUERea0225558-6k_nlspharma.htm
2024-12-196-K/A2024-12-19AMENDMENT NO. 1 TO FORM 6-Kea0225358-6ka1_nlspharma.htm
2024-12-196-K2024-12-19REPORT OF FOREIGN PRIVATE ISSUERea0225128-6k_nlspharma.htm
2024-12-176-K2024-12-17REPORT OF FOREIGN PRIVATE ISSUERea0224882-6k_nlspharm.htm
2024-12-116-K2024-12-11REPORT OF FOREIGN PRIVATE ISSUERea0222021-6k_nlspharma.htm
2024-12-106-K/A2024-12-10AMENDMENT NO. 1 TO FORM 6-Kea0224173-6ka_nlspharma.htm
2024-12-046-K2024-12-04REPORT OF FOREIGN PRIVATE ISSUERea0223564-6k_nlspharma.htm
2024-12-036-K2024-12-03REPORT OF FOREIGN PRIVATE ISSUERea0223410-6k_nlspharma.htm
2024-11-186-K2024-11-18REPORT OF FOREIGN PRIVATE ISSUERea0221578-6k_nlspharma.htm
2024-11-156-K2024-11-15REPORT OF FOREIGN PRIVATE ISSUERea0221081-6k_nlspharma.htm
2024-11-126-K2024-11-12REPORT OF FOREIGN PRIVATE ISSUERea0220690-6k_nlspharma.htm
2024-11-086-K2024-11-08REPORT OF FOREIGN PRIVATE ISSUERea0220538-6k_nlspharma.htm
2024-11-066-K2024-11-06REPORT OF FOREIGN PRIVATE ISSUERea0220191-6k_nlspharma.htm
2024-11-056-K2024-11-05REPORT OF FOREIGN PRIVATE ISSUERea0219853-6k_nlspharma.htm
2024-11-046-K2024-11-04REPORT OF FOREIGN PRIVATE ISSUERea0219780-6k_nlspharma.htm
2024-10-286-K2024-10-28REPORT OF FOREIGN PRIVATE ISSUERea0218650-6k_nlspharma.htm
2024-10-226-K2024-10-22REPORT OF FOREIGN PRIVATE ISSUERea0218016-6k_nlspharma.htm
2024-10-186-K2024-06-30REPORT OF FOREIGN PRIVATE ISSUERea0216876-6k_nlspharma.htm
2024-10-156-K2024-10-15REPORT OF FOREIGN PRIVATE ISSUERea0217575-6k_nlspharm.htm
2024-10-116-K2024-10-11REPORT OF FOREIGN PRIVATE ISSUERea0217306-6k_nlspharma.htm
2024-10-116-K2024-10-11REPORT OF FOREIGN PRIVATE ISSUERea0217306-6k_nlspharm.htm
2024-10-106-K2024-10-10REPORT OF FOREIGN PRIVATE ISSUERea0217306-6k_nlspharma.htm
2024-10-086-K2024-10-07REPORT OF FOREIGN PRIVATE ISSUERea0217013-6k_nlspharma.htm
2024-10-016-K2024-10-01REPORT OF FOREIGN PRIVATE ISSUERea0216382-6k_nlspharma.htm
2024-09-256-K2024-09-25REPORT OF FOREIGN PRIVATE ISSUERea0215301-6k_nlspharma.htm
2024-09-196-K2024-09-19REPORT OF FOREIGN PRIVATE ISSUERea0215086-6k_nlspharma.htm
2024-09-176-K2024-09-16REPORT OF FOREIGN PRIVATE ISSUERea0214740-6k_nlspharma.htm
2024-09-136-K2024-09-13REPORT OF FOREIGN PRIVATE ISSUERea0213701-6k_nlspharma.htm
2024-08-266-K2024-08-26REPORT OF FOREIGN PRIVATE ISSUERea0212353-6k_nlspharma.htm
2024-08-156-K2024-08-15REPORT OF FOREIGN PRIVATE ISSUERea0211447-6k_nlspharma.htm
2024-08-146-K2024-08-14REPORT OF FOREIGN PRIVATE ISSUERea0211431-6k_nlspharma.htm
2024-07-306-K2024-07-30REPORT OF FOREIGN PRIVATE ISSUERea0210217-6k_nlspharma.htm
2024-07-016-K2024-07-01REPORT OF FOREIGN PRIVATE ISSUERea0208723-6k_nlspharma.htm
2024-06-276-K2024-06-27REPORT OF FOREIGN PRIVATE ISSUERea0208624-6k_nlspharma.htm
2024-06-256-K2024-06-25REPORT OF FOREIGN PRIVATE ISSUERea0208478-6k_nlspharm.htm
2024-06-256-K2024-06-25REPORT OF FOREIGN PRIVATE ISSUERea0208451-6k_nlspharm.htm
2024-06-116-K2024-06-11REPORT OF FOREIGN PRIVATE ISSUERea0207627-6k_nlspharma.htm
2024-06-066-K2024-06-06REPORT OF FOREIGN PRIVATE ISSUERea0207453-6k_nlspharma.htm
2024-05-316-K2024-05-31REPORT OF FOREIGN PRIVATE ISSUERea0207051-6k_nlspharma.htm
2024-05-286-K2024-05-28REPORT OF FOREIGN PRIVATE ISSUERea0206912-6k_nlsphar.htm
2024-05-246-K2024-05-24REPORT OF FOREIGN PRIVATE ISSUERea0206805-6k_nlsphar.htm
2024-05-226-K2024-05-22REPORT OF FOREIGN PRIVATE ISSUERea0206687-6k_nlsphar.htm
2024-05-146-K2024-05-14REPORT OF FOREIGN PRIVATE ISSUERea0206095-6k_nlspharma.htm
2024-04-196-K2024-04-19REPORT OF FOREIGN PRIVATE ISSUERea0204274-6k_nlspharma.htm
2024-04-156-K2024-04-15REPORT OF FOREIGN PRIVATE ISSUERea0203562-6k_nlspharma.htm
2024-04-086-K2024-04-08REPORT OF FOREIGN PRIVATE ISSUERea0203502-6k_nlspharma.htm
2024-03-216-K2024-03-21REPORT OF FOREIGN PRIVATE ISSUERea0202255-6k_nlspharma.htm
2024-03-206-K2024-03-20REPORT OF FOREIGN PRIVATE ISSUERea0202162-6k_nlspharma.htm
2024-03-206-K2024-03-20REPORT OF FOREIGN PRIVATE ISSUERea0202110-6k_nlspharma.htm
2024-03-206-K2024-03-19REPORT OF FOREIGN PRIVATE ISSUERea0202109-6k_nlspharma.htm
2024-03-146-K2024-03-13REPORT OF FOREIGN PRIVATE ISSUERea0201757-6k_nlspharma.htm
2024-03-116-K2024-03-11REPORT OF FOREIGN PRIVATE ISSUERea0201436-6k_nlspharma.htm
2024-02-236-K2024-02-23REPORT OF FOREIGN PRIVATE ISSUERea0200575-6k_nlspharma.htm
2024-01-126-K2024-01-12REPORT OF FOREIGN PRIVATE ISSUERea191532-6k_nlspharma.htm
Advertisement